Earlier initiation of treatment recommended in using erythropoietic agents for chemotherapy-induced anemia
- PMID: 15357515
Item in Clipboard
Earlier initiation of treatment recommended in using erythropoietic agents for chemotherapy-induced anemia
J Support Oncol.
2004 Jul-Aug.
No abstract available
Similar articles
-
Epoetin alfa and chemotherapy: a summary of two studies on preventive and maintenance use.J Support Oncol. 2003 Jul-Aug;1(2):104, 120. J Support Oncol. 2003. PMID: 15352653 No abstract available.
-
Treatment options for anemia, taking risks into consideration: erythropoiesis-stimulating agents versus transfusions.Oncologist. 2008;13 Suppl 3:27-32. doi: 10.1634/theoncologist.13-S3-27. Oncologist. 2008. PMID: 18458122 Review.
-
Epoetin beta once weekly: review of its efficacy and safety in patients with chemotherapy-induced anemia.Expert Rev Anticancer Ther. 2008 Jun;8(6):875-85. doi: 10.1586/14737140.8.6.875. Expert Rev Anticancer Ther. 2008. PMID: 18533797 Review.
-
[Experience with recombinant erythropoietin for anemia in children with malignant tumors].Vopr Onkol. 2000;46(1):88-90. Vopr Onkol. 2000. PMID: 10789233 Russian. No abstract available.
-
September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents.Oncologist. 2008;13 Suppl 3:33-6. doi: 10.1634/theoncologist.13-S3-33. Oncologist. 2008. PMID: 18458123